Skip to main content
×
Home
    • Aa
    • Aa

Healthcare Antibiotic Resistance Prevalence – DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia

  • Jacqueline Reuben (a1), Nancy Donegan (a2), Glenn Wortmann (a3), Roberta DeBiasi (a4), Xiaoyan Song (a5), Princy Kumar (a6), Mary McFadden (a7), Sylvia Clagon (a8), Janet Mirdamadi (a9), Diane White (a10), Jo Ellen Harris (a11), Angella Browne (a12), Jane Hooker (a13), Michael Yochelson (a14), Milena Walker (a15), Gary Little (a15), Gail Jernigan (a16), Kathleen Hansen (a17), Brenda Dockery (a17), Brendan Sinatro (a2), Morris Blaylock (a18), Kimary Harmon (a18), Preetha Iyengar (a1), Trevor Wagner (a19), Jo Anne Nelson (a2) and HARP Study Team...
Abstract
OBJECTIVE

Carbapenem-resistant Enterobacteriaceae (CRE) are a significant clinical and public health concern. Understanding the distribution of CRE colonization and developing a coordinated approach are key components of control efforts. The prevalence of CRE in the District of Columbia is unknown. We sought to determine the CRE colonization prevalence within healthcare facilities (HCFs) in the District of Columbia using a collaborative, regional approach.

DESIGN

Point-prevalence study.

SETTING

This study included 16 HCFs in the District of Columbia: all 8 acute-care hospitals (ACHs), 5 of 19 skilled nursing facilities, 2 (both) long-term acute-care facilities, and 1 (the sole) inpatient rehabilitation facility.

PATIENTS

Inpatients on all units excluding psychiatry and obstetrics-gynecology.

METHODS

CRE identification was performed on perianal swab samples using real-time polymerase chain reaction, culture, and antimicrobial susceptibility testing (AST). Prevalence was calculated by facility and unit type as the number of patients with a positive result divided by the total number tested. Prevalence ratios were compared using the Poisson distribution.

RESULTS

Of 1,022 completed tests, 53 samples tested positive for CRE, yielding a prevalence of 5.2% (95% CI, 3.9%–6.8%). Of 726 tests from ACHs, 36 (5.0%; 95% CI, 3.5%–6.9%) were positive. Of 244 tests from long-term-care facilities, 17 (7.0%; 95% CI, 4.1%–11.2%) were positive. The relative prevalence ratios by facility type were 0.9 (95% CI, 0.5–1.5) and 1.5 (95% CI, 0.9–2.6), respectively. No CRE were identified from the inpatient rehabilitation facility.

CONCLUSION

A baseline CRE prevalence was established, revealing endemicity across healthcare settings in the District of Columbia. Our study establishes a framework for interfacility collaboration to reduce CRE transmission and infection.

Infect Control Hosp Epidemiol 2017;38:921–929

Copyright
Corresponding author
Address correspondence to Jacqueline Reuben, DC Department of Health, Center for Policy Planning and Evaluation, 899 N Capitol St NE, 6th Floor, Washington, DC 20001 (jacqueline.reuben@dc.gov).
Footnotes
Hide All

PREVIOUS PRESENTATION. These study results were presented at 2016 ID Week on October 28, 2016, in New Orleans, Louisiana.

Footnotes
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. DM Sievert , P Ricks , JR Edwards , et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:114.

2. SY Won , LS Munoz-Price , K Lolans , et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532540.

3. MJ Ray , MY Lin , RA Weinstein , WE Trick . Spread of carbapenem-resistant Enterobacteriaceae among Illinois healthcare facilities: the role of patient sharing. Clin Infect Dis 2016;63:889893.

4. K Prabaker , MY Lin , M McNally , et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012;33:11931199.

6. D Ben-David , Y Maor , N Keller , et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620626.

7. G Patel , S Huprikar , SH Factor , SG Jenkins , DP Calfee . Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:10991106.

8. H Yigit , AM Queenan , GJ Anderson , et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob Agents Chemother 2001;45:11511161.

9. KK Kumarasamy , MA Toleman , TR Walsh , et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597602.

10. P Nordmann , L Dortet , L Poirel . Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 2012;18:263272.

12. BY Lee , SM McGlone , Y Song , et al. Social network analysis of patient sharing among hospitals in Orange County, California. Am J Pub Health 2011;101:707713.

14. BE Ostrowsky , WE Trick , AH Sohn , et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:14271433.

15. MJ Schwaber , Y Carmeli . An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014;58:697703.

16. RB Slayton , D Toth , BY Lee , et al. Vital signs: estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities—United States. Morb Mortal Wkly Rep 2015;64:826.

17. GT Walker , TJ Rockweiler , RK Kersey , et al. Analytical performance of multiplexed screening test for 10 antibiotic resistance genes from perianal swab samples. Clin Chem 2016;62:353359.

18. X Song , D Toal , T Walker , ED Perez-Albuerne , JM Campos , RL DeBiasi . Multidrug-resistant organism colonization in a high-risk pediatric patient population. Infect Control Hosp Epidemiol 2016;37:614616.

19. KM Shaw , JE Harper , PS Vagnone , R Lynfield . Establishing surveillance for carbapenem-resistant Enterobacteriaceae in Minnesota, 2012. Infect Control Hosp Epidemiol 2014;35:451453.

20. AY Guh , SN Bulens , Y Mu , et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012–2013. JAMA 2015;314:14791487.

21. BM Brennan , JR Coyle , D Marchaim , et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol 2014;35:342349.

22. EC Pereira , KM Shaw , PMS Vagnone , et al. Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis–St Paul metropolitan area. Infect Control Hosp Epidemiol 2014;35:423425.

23. CD Pfeiffer , MC Cunningham , T Poissant , et al. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region. Infect Control Hosp Epidemiol 2014;35:356361.

24. LM Pisney , MA Barron , E Kassner , D Havens , NE Madinger . Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae at an acute care hospital. Infect Control Hosp Epidemiol 2014;35:434436.

25. JK Johnson , LE Wilson , L Zhao , K Richards , KA Thom , AD Harris . Point prevalence of Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae in Maryland. Infect Control Hosp Epidemiol 2014;35:443445.

26. AJ Mathers , M Poulter , D Dirks , J Carroll , CD Sifri , KC Hazen . Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol 2014;35:350355.

28. M Swaminathan , S Sharma , SP Blash , et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013;34:809817.

29. M Fitzpatrick , T Zembower , M Malczynski , C Qi , MK Bolon . Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol 2014;35:419422.

30. V Schechner , K Straus-Robinson , D Schwartz , et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 2009;47:32613265.

31. K Singh , KA Mangold , K Wyant , et al. Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol 2012;50:25962600.

32. S Vasoo , SA Cunningham , PC Kohner , et al. Rapid and direct real-time detection of blaKPC and blaNDM from surveillance samples. J Clin Microbiol 2013;51:36093615.

33. JM Blair , MA Webber , AJ Baylay , DO Ogbolu , LJ Piddock . Molecular mechanisms of antibiotic resistance. Nature Revs Microbiol 2015;13:4251.

34. AC Weintrob , MP Roediger , M Barber , et al. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010;31:330337.

35. MY Lin , K Lolans , DW Blom , et al. The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol 2014;35:440442.

36. M Buehlmann , H Fankhauser , R Laffer , T Bregenzer , AF Widmer . The inguinal skin: an important site of colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Infect Control Hosp Epidemioly 2010;31:427428.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×
Type Description Title
WORD
Supplementary Materials

Reuben supplementary material
Figure S1 and Table S1

 Word (64 KB)
64 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 48
Total number of PDF views: 343 *
Loading metrics...

Abstract views

Total abstract views: 1439 *
Loading metrics...

* Views captured on Cambridge Core between 15th June 2017 - 22nd August 2017. This data will be updated every 24 hours.